Skip to main content
. 2021 Jul 12;19:302. doi: 10.1186/s12967-021-02980-6

Table 4.

Clinical trials based on MSCs-exosomes registered in ClinicalTrials.gov (May 2021)

Condition Source Study Phase Participant Number Route Study Location NCT Number
ARDS BM 1/2 169 Inhalation China NCT04602104
Lung diseases N.A 1 27 Inhalation China NCT04313647
COVID-19 N.A 1/2 30 Inhalation Russian NCT04491240
BPD BM 1 18 Intravenous USA NCT03857841
COVID-19 BM 1 24 Inhalation China NCT04276987
MODS UC N.A 60 Intravenous China NCT04356300
Drug-Resistant AT 1/2 60 Intravenous China NCT04544215
Chronic wounds WJ 1 38 Topical Indonesia NCT04134676
Ischemic stroke N.A 1/2 5 Intravenous Iran NCT03384433
Dry eye UC 1/2 27 Eye Drops China NCT04213248
Macular holes UC Early 1 44 Eye Drops China NCT03437759
AD AT 1/2 9 Nasal Drops China NCT04388982
EB BM 1/2 10 Topical NA NCT04173650

Bone marrow (BM), Adipose tissue (AT), Wharton’s jelly (WJ), Umbilical cord (UC), Coronavirus disease 2019 (COVID-19), Bronchopulmonary dysplasia (BPD), Alzheimer’s diseases (AD), Acute respiratory distress syndrome (ARDS), Epidermolysis bullosa (EB), Multiple organ dysfunction syndromes (MODS), Not available (N.A)